Skip to main content
. 2022 Dec 5;32(Suppl 12):S36–S46. doi: 10.2188/jea.JE20210386

Figure 2. Multivariable-adjusted hazard ratios (HRs) or odds ratios (ORs) of overweight, hypertension, hypo-HDL cholesterolemia, diabetes mellitus, metabolic syndrome and hyperuricemia cases among evacuees compared with non-evacuees before (FY 2008–FY 2010) and after (FY 2011–FY 2012) the disaster.
Overweight: body mass index ≥25 kg/m2; Hypertension: systolic blood pressure (SBP) ≥140 mm Hg, diastolic blood pressure (DBP) ≥90 mm Hg, or use of antihypertensive medication; Hypo HDL-C; HDL-C <40 mg/dL; Diabetes mellitus: HbA1c level ≥6.5%, fasting plasma glucose level ≥126 mg/dL, or use of antihyperglycemic medication; Metabolic syndrome: visceral obesity (waist circumference ≥85 cm in men and ≥90 cm in women) and the presence of at least two of three abnormalities (fasting serum triglycerides ≥150 mg/dL and/or HDL-C <40 mg/dL or medication use for dyslipidemia; SBP ≥130 mm Hg and/or DBP ≥85 mm Hg or use of antihypertensive medication; and fasting plasma glucose ≥110 mg/dL or use of antihyperglycemic medication); Hyperuricemia: serum uric acid level ≥7.0 mg/dL. Adjusted variables: age, smoking status, drinking status (all), body mass index (overweight, hypertension, hypo HDL-C, diabetes), waist circumference (metabolic syndrome, hyperuricemia), sex (diabetes), SBP (hypertension, hypo HDL-C, diabetes), alanine aminotransferase (hypo HDL-C, diabetes), γ-glutamyl transpeptidase (hypo HDL-C, diabetes), diabetes (hypo HDL-C), HDL-C (diabetes), LDL-C (diabetes), body weight change (metabolic syndrome), physical activity (metabolic syndrome, hyperuricemia), and sleep quality (metabolic syndrome). *HR was calculated by using combined data of men and women for diabetes. FY, fiscal year; HDL-C, high-density lipoprotein cholesterolemia; LDL-C, low-density lipoprotein cholesterolemia.

Figure 2.